This trial is active, not recruiting.

Conditions cytomegalovirus retinitis, hiv infections
Treatment cidofovir
Sponsor Gilead Sciences
Collaborator Anderson Clinical Research
Trial identifier NCT00002384, 276A, 96ACR-GIL1, GS-95-120


Incomplete Closed Protocol

United States No locations recruiting
Other countries No locations recruiting

Study Design

Primary purpose treatment

Eligibility Criteria

Male or female participants at least 13 years old.

Information not available

Additional Information

Official title Vistide (Cidofovir Intravenous) Treatment IND Protocol for Relapsing Cytomegalovirus Retinitis in Patients With AIDS
Trial information was received from ClinicalTrials.gov and was last updated in June 2005.
Information provided to ClinicalTrials.gov by NIH AIDS Clinical Trials Information Service.